News

• 26.03.2025 Interview with Grzegorz Stefański, CEO of Urteste, on Parkiet TV
• 20.03.2025 Urteste Receives Patent in Poland for Breakthrough Bile Duct Cancer Diagnostic Marker
• 17.02.2025 Urteste expects to receive the FDA's position on the Panuri project by the end of March
• 04.12.2024 Urteste Secures Japanese Patent for Pancreatic Cancer Diagnostic Marker
• 02.12.2024 Status of the PANURI Project and Development Plans for Urteste - Webinar with the Management Board
• 22.11.2024 Urteste plans to launch a clinical trial for its breast cancer test project in early 2026
• 20.11.2024 Urteste Receives Patent in Poland for Breakthrough Ovarian Cancer Marker
• 11.10.2024 Urteste begins cooperation with Avania, a leading global MedTech clinical research organization
• 23.09.2024 r. Investors Zone: Urteste breast cancer detection test selected for PLN 11.5 million grant by the Polish Agency for Enterprise Development
• 03-06.06.2024 Urteste at the BIO International Convention in San Diego
• 17.05.2024 Urteste received a patent for endometrial cancer in the Multi-Cancer Project
• 11.04.2024 Stooq.pl: Urteste has successfully developed a diagnostic test prototype for detecting brain tumours
• 28.12.2023r. Urteste S.A. will receive PLN 38.3 million in funding from PARP
• 19.12.2023r. Obtaining Patent Protection for Two Inventions in the Multi-Cancer Project
• 12.12.2023r. PAP Biznes: FDA Meeting Confirms Clinical Development Direction in the Panuri Project